3rd Quarter - Report

THE RUSSELL GROUP, INC. for GENERIC PHARMACEUTICAL ASSOCIATION

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S. 23, H.R. 1249 - America Invents Act (2011) - Issues relative to patent quality.

LobbyistCovered position, as disclosed
EDWARD BARRON —

Contacted: Patent & Trademark Office (PTO); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 23 (112th), H.R. 1249 (112th)

Pharmacy PHA

Issues relative to generic pharmaceuticals and generic biologics; FY 2011 and FY 2012 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); funding FDA Office of Generic Drugs; H.R. 1249, S. 23 - America Invents Act (2011).

LobbyistCovered position, as disclosed
EDWARD BARRON —
TYSON REDPATH —
RANDALL RUSSELL —

Contacted: Food & Drug Administration (FDA); Patent & Trademark Office (PTO); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 23 (112th), H.R. 1249 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.